Literature DB >> 9445089

Exposure to in utero irradiation produces disruption of radial glia in rats.

S N Roper1, L A Abraham, W J Streit.   

Abstract

In utero exposure of fetal rats to gamma-irradiation produces diffuse cortical dysplasia and neuronal heterotopia. This study examined the effects of in utero irradiation on radial glia and astrocytes in the perinatal period in order to better understand the specific mechanisms which produce cortical dysgenesis in this model. Fetal rats were exposed to 225 cGy of gamma-irradiation on embryonic day 17. Vibratome sections were processed for cresyl violet staining and immunohistochemistry with Rat-401 and an antibody for glial fibrillary acidic protein (GFAP) on E20, P0, P2, and P4. In utero irradiation produced a profound disruption of the radial glia which lasted throughout the perinatal period. This injury coincided with the location of the most severe cortical dysplasia in this model. In addition, there was increased GFAP immunoreactivity in the cortex and the striatum when compared to nonirradiated controls on P0, P2, and P4. Our results demonstrate that in utero irradiation has a lasting, injurious effect on radial glia and also incites a reactive astrocytic response. This suggests that disruption of radial glial fibers by gamma-irradiation is a major factor in the pathogenesis of cortical dysgenesis in this model.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9445089     DOI: 10.1159/000111249

Source DB:  PubMed          Journal:  Dev Neurosci        ISSN: 0378-5866            Impact factor:   2.984


  10 in total

1.  Epileptogenesis in the Dysplastic Brain: A Revival of Familiar Themes.

Authors:  Scott C. Baraban
Journal:  Epilepsy Curr       Date:  2001-09       Impact factor: 7.500

2.  Abnormal morphological and functional organization of the hippocampus in a p35 mutant model of cortical dysplasia associated with spontaneous seizures.

Authors:  H J Wenzel; C A Robbins; L H Tsai; P A Schwartzkroin
Journal:  J Neurosci       Date:  2001-02-01       Impact factor: 6.167

3.  Irradiation exacerbates cortical cytopathology in the Eker rat model of tuberous sclerosis complex, but does not induce hyperexcitability.

Authors:  Naranzogt Tschuluun; H Jürgen Wenzel; Philip A Schwartzkroin
Journal:  Epilepsy Res       Date:  2006-09-29       Impact factor: 3.045

4.  Reduced inhibition in an animal model of cortical dysplasia.

Authors:  W J Zhu; S N Roper
Journal:  J Neurosci       Date:  2000-12-01       Impact factor: 6.167

5.  Dividing precursor cells of the embryonic cortical ventricular zone have morphological and molecular characteristics of radial glia.

Authors:  Stephen C Noctor; Alexander C Flint; Tamily A Weissman; Winston S Wong; Brian K Clinton; Arnold R Kriegstein
Journal:  J Neurosci       Date:  2002-04-15       Impact factor: 6.167

Review 6.  Genetic animal models of malformations of cortical development and epilepsy.

Authors:  Michael Wong; Steven N Roper
Journal:  J Neurosci Methods       Date:  2015-04-21       Impact factor: 2.390

7.  Populations of radial glial cells respond differently to reelin and neuregulin1 in a ferret model of cortical dysplasia.

Authors:  Sylvie Poluch; Sharon L Juliano
Journal:  PLoS One       Date:  2010-10-28       Impact factor: 3.240

8.  Impaired structural and functional development of cerebellum following gestational exposure of deltamethrin in rats: role of reelin.

Authors:  Kamendra Kumar; Nisha Patro; Ishan Patro
Journal:  Cell Mol Neurobiol       Date:  2013-05-17       Impact factor: 5.046

9.  Degree of Cajal-Retzius Cell Mislocalization Correlates with the Severity of Structural Brain Defects in Mouse Models of Dystroglycanopathy.

Authors:  Helen S Booler; Josie L Williams; Mark Hopkinson; Susan C Brown
Journal:  Brain Pathol       Date:  2015-10-12       Impact factor: 6.508

10.  Atypical febrile seizures, mesial temporal lobe epilepsy, and dual pathology.

Authors:  Nathalie T Sanon; Sébastien Desgent; Lionel Carmant
Journal:  Epilepsy Res Treat       Date:  2012-04-23
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.